{{Infobox medical intervention
...'、'''pharmaceutical drug'''、'''medicinal drug'''、または単に'''drug'''と呼ばれる）とは、[[medical diagnosis/ja|診断]]、[[cure/ja|治療]]、[[disease/ja|病気]]の[[preventive medicine/ja
...
58 KB (1,845 words) - 17:09, 5 November 2023
{{Infobox medical condition (new)
...syndrome/ja|呼吸困難]]が高血圧と関連することがある。年長の乳児および小児では、高血圧は頭痛、原因不明の易刺激性、[[fatigue (medical)/ja|fatigue]]、発育不全、[[blurred vision/ja|かすみ目]]、[[epistaxis/ja|鼻出血]]、および[[bel
...
59 KB (1,712 words) - 11:18, 4 March 2024
<!-- Definition and medical uses -->
{{Anchor|Medical uses}}
...
53 KB (1,662 words) - 16:42, 12 March 2024
...cardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whe
...2006 "Hypertension: Management of Hypertension in Adults in Primary Care" guideline of the [[National Institute for Health and Clinical Excellence]], downgrade
...
23 KB (3,174 words) - 17:14, 5 November 2023
...c''' or '''subsequent entry biologic''') is a [[biopharmaceutical|biologic medical product]] that is almost an identical copy of an original product that is m
...on of similar biotherapeutic products (SBPs)" in 2009. The purpose of this guideline is to provide an international norm for evaluating biosimilars.
...
21 KB (2,692 words) - 09:55, 20 March 2024
{{Short description|Medical injection into a muscle}}
{{Infobox medical intervention
...
29 KB (4,153 words) - 17:21, 3 January 2023
...cardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whe
...2006 "Hypertension: Management of Hypertension in Adults in Primary Care" guideline of the [[National Institute for Health and Clinical Excellence]], downgrade
...
24 KB (3,266 words) - 17:11, 5 November 2023
...c''' or '''subsequent entry biologic''') is a [[biopharmaceutical|biologic medical product]] that is almost an identical copy of an original product that is m
...on of similar biotherapeutic products (SBPs)" in 2009. The purpose of this guideline is to provide an international norm for evaluating biosimilars.
...
21 KB (2,770 words) - 09:54, 20 March 2024
{{Infobox medical intervention
...[pharmacotherapy|pharmacotherapy]]) is an important part of the [[medicine|medical field]] and relies on the science of [[pharmacology|pharmacology]] for cont
...
52 KB (6,923 words) - 17:09, 5 November 2023
{{Infobox medical condition (new)
...'''high blood pressure''', is a [[Chronic condition|long-term]] [[Disease|medical condition]] in which the [[blood pressure]] in the [[artery|arteries]] is p
...
51 KB (6,965 words) - 22:04, 29 February 2024
{{Infobox medical intervention
...[pharmacotherapy|pharmacotherapy]]) is an important part of the [[medicine|medical field]] and relies on the science of [[pharmacology|pharmacology]] for cont
...
54 KB (7,245 words) - 17:08, 5 November 2023
{{Infobox medical condition (new)
...'''high blood pressure''', is a [[Chronic condition|long-term]] [[Disease|medical condition]] in which the [[blood pressure]] in the [[artery|arteries]] is p
...
52 KB (7,139 words) - 22:02, 29 February 2024
A study was conducted measuring the effects of guideline changes on LDL cholesterol reporting and control for diabetes visits in the
...events within one year, contrary to the longstanding claims by many in the medical industry that the superiority over existing methods was weak, even by state
...
26 KB (3,765 words) - 12:51, 8 March 2024
A study was conducted measuring the effects of guideline changes on LDL cholesterol reporting and control for diabetes visits in the
...events within one year, contrary to the longstanding claims by many in the medical industry that the superiority over existing methods was weak, even by state
...
27 KB (3,859 words) - 12:51, 8 March 2024
{{short description|Medical condition in which excess body fat harms health}}
{{Infobox medical condition (new)
...
69 KB (10,124 words) - 14:18, 5 March 2024
{{short description|Medical condition in which excess body fat harms health}}
{{Infobox medical condition (new)
...
71 KB (10,348 words) - 14:18, 5 March 2024
{{Infobox medical condition (new)
Diagnosis of CKD is largely based on [[medical history|history]], [[physical examination|examination]], and [[urine dipsti
...
39 KB (5,450 words) - 21:53, 25 February 2024
{{Infobox medical condition (new)
Diagnosis of CKD is largely based on [[medical history|history]], [[physical examination|examination]], and [[urine dipsti
...
40 KB (5,586 words) - 21:51, 25 February 2024
<!-- Definition and medical uses -->
== Medical uses ==
...
42 KB (5,783 words) - 19:35, 11 March 2024
<!-- Definition and medical uses -->
== Medical uses == <!--T:11-->
...
44 KB (5,999 words) - 19:35, 11 March 2024